Reliq Well being Applied sciences, Inc. Information Q2 FY2022 Quarterly Monetary Statements, Gives Company Replace | 2022-03-01 | Press Releases

HAMILTON, Ontario, March 01, 2022 (GLOBE NEWSWIRE) — Reliq Well being Applied sciences Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Firm”), a quickly rising international healthcare know-how firm that focuses on growing modern Digital Care options for the multi-billion greenback Healthcare market, as we speak introduced that the consolidated monetary statements (“Monetary Statements”) and Administration’s Dialogue and Evaluation (“MD&A”) for the quarter ended December 31, 2021, are actually out there on the Firm’s profile on SEDAR (

“We now have now filed our quarterly financials for Q2 Fiscal Yr 2022,” mentioned Dr. Lisa Crossley, CEO of Reliq Well being Applied sciences, Inc. “The primary two quarters of FY2022 have been a interval of speedy progress for the Firm. Revenues for the interval from July 1 – December 31, 2021 have been $3,748,292 as in comparison with $843,449 for the interval from January 1 – June 30, 2021, a rise of over 344%. Gross Margin improved to 74% in Q2 FY2022 as in comparison with 58% for FY2021. Regardless of the dramatic resurgence of COVID (Omicron variant) in Q2 FY2022, the Firm reached a income run price of $2 Million/month as of December 31, 2021, the place run price represents the variety of subscribers onboarded as of the given date. Income run price is a number one indicator of income that’s anticipated to be acknowledged throughout the following two to a few months as sufferers full coaching and adapt to utilizing the platform persistently in an effort to attain the required compliance thresholds. As beforehand disclosed, throughout the pandemic the Firm prolonged versatile fee phrases to purchasers and acquired equally beneficiant fee phrases from our key suppliers. Receivables older than one 12 months are anticipated to be paid in full by our purchasers by the tip of March 2022 and the Firm expects to gather all different receivables in a well timed method going ahead now that the majority of our purchasers have resumed regular operations.”

The Firm can also be happy to supply the next company replace.

1. Highlights from Q2 FY2022 Quarterly Monetary Statements

Through the interval ending December 31, 2021 and subsequent, the Firm:

  • Elevated gross sales earlier than returns quarter-over-quarter by 36% to $2,183,075 relative to the earlier quarter (Q1 FY 2022 – $1,608,168).
  • Elevated gross earnings quarter-over-quarter to $1,583,702 in Q2 FY2022 (Q1 FY2022: $1,159,024). Gross Margin for the quarter was 74%, a big improve as in comparison with FY 2021 (58%).
  • Elevated working capital considerably to $5,921,491 as at December 31, 2021 (June 30, 2021 – $939,933).
  • Lowered present liabilities to $945,347 as at December 31, 2021 (June 30, 2021 – $2,238,209).
  • After adjusting for non-cash bills together with share-based compensation and accretion and one-time non-reoccurring bills together with authorized charges associated to the settlement of the proposed Class Motion declare and bills referring to prior quarters, the Firm’s adjusted EBITDA (achieve) for Q2 FY2022 was $48,062 (Q2 FY2021 adjusted EBITDA (loss): $1,684,491).
  • Signed implementation plan agreements with present purchasers which might be anticipated so as to add over 10,000 new sufferers to the platform in Calendar Yr 2022, leveraging the brand new Medicare Distant Therapeutic Monitoring billing codes for sufferers with musculoskeletal or respiratory circumstances. 5 new billing codes for RTM have been launched on January 1, 2022, permitting clinicians to supply ongoing in-home remedy and monitoring for sufferers with musculoskeletal and respiratory circumstances. RTM entails having sufferers use medical units that acquire non-physiological knowledge equivalent to remedy/treatment adherence and remedy/treatment response, and likewise permits for affected person self-reporting of key metrics equivalent to ache degree, mobility, nighttime waking as a result of respiratory difficulties, and so on. The brand new RTM codes have elevated Reliq’s goal affected person inhabitants by over 20 million newly eligible sufferers to over 57 Million complete eligible sufferers.
  • Signed an settlement with Information Gentle Logic (DSL) to supply iUGO Care to DSL’s current and new purchasers. Information Gentle Logic presently has over 600 residence well being and hospice care company purchasers who work with greater than 1,000 main care physicians to supply care to over 500,000 Medicare and Medicaid sufferers. Reliq expects to start onboarding DSL’s sufferers in Q2 Calendar Yr 2022 and to ramp as much as including over 50,000 new sufferers per 12 months every year starting in 2023, at an estimated income of $60 per affected person monthly.
  • Signed an settlement with Cognizant to leverage Cognizant’s Care Administration assets for future deployments of Reliq’s iUGO Care software program to massive scale purchasers. Cognizant offers providers to 300+ well being techniques and over 347,000 care suppliers who collectively present care to over 200 million lives globally. The settlement with Cognizant will permit Reliq to scale to new ranges and supply even the biggest healthcare organizations with confidence that the Firm can meet the wants of their affected person populations, regardless of the scale, permitting Reliq to entry new alternatives to supply digital care to a lot bigger affected person populations each throughout the US and globally.
  • Signed contracts with 39 new US main care doctor practices and 10 different healthcare organizations in specialties together with hospice care, nephrology, orthopedics, long run care, cardiology and care administration.
  • Signed contracts with 9 new residence well being companies within the US.

2. Overview of Income Run Charge, Income Recognition and Steering

Regardless of the dramatic resurgence of COVID (Omicron variant) in Q2 FY2022, the Firm reached a income run price of $2 Million monthly or $24 million per 12 months on the finish of the quarter (December 31, 2021). Income run price is calculated utilizing the variety of subscribers as of the given timepoint and is a sign of the income anticipated over the subsequent 12 months, excluding new purchasers and sufferers subsequently introduced throughout the given 12 months. New affected person income is usually acknowledged after the second or third full month {that a} affected person is on the platform when sufferers usually attain the required compliance thresholds. Subsequently, income run price is a number one indicator of income which is predicted to be acknowledged roughly three months later. Income run price differs from income steering in that steering consists of anticipated progress over the 12 months.

3. Outlook for Calendar Yr 2022

The Firm expects to generate $40 Million CAD in income in Calendar Yr 2022.

4. Date for Webinar to Evaluation Q3 FY2022 Financials

The Firm’s consolidated monetary statements for Q3 FY2022 (quarter ending March 31, 2022) are as a result of be filed on or earlier than Could 30, 2022. The webinar to evaluation the monetary statements can be scheduled on or earlier than Could 31, 2022.

About Reliq Well being

Reliq Well being Applied sciences is a quickly rising international healthcare know-how firm that develops modern Digital Care options for the multi-billion greenback Healthcare market. Reliq’s highly effective iUGO Care platform helps care coordination and community-based healthcare. iUGO Care permits advanced sufferers to obtain prime quality care at residence, enhancing well being outcomes, enhancing high quality of life for sufferers and households and lowering the price of care supply. iUGO Care offers real-time entry to distant affected person monitoring knowledge, permitting for well timed interventions by the care group to forestall pricey hospital readmissions and ER visits. Reliq Well being Applied sciences trades on the TSX Enterprise underneath the image RHT and on the OTC as RQHTF.


“Dr. Lisa Crossley”

CEO and Director

For additional data please contact:

Firm Contact

Investor Relations at [email protected]

US Investor Relations Contact

Investor Relations

Lytham Companions, LLC

Ben Shamsian

New York | Phoenix


[email protected]

Neither the TSX Enterprise Alternate nor its Regulation Companies Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Alternate) accepts accountability for the adequacy or accuracy of this launch.

Cautionary Statements Relating to Ahead Trying Data

Sure statements on this press launch represent forward-looking statements, throughout the which means of relevant securities legal guidelines. All statements that aren’t historic details, together with with out limitation, statements relating to future estimates, plans, applications, forecasts, projections, targets, assumptions, expectations or beliefs of future efficiency, are “forward-looking statements”.

We warning you that such “forward-looking statements” contain recognized and unknown dangers and uncertainties that would trigger precise and future occasions to vary materially from these anticipated in such statements.

Ahead-looking statements embrace, however aren’t restricted to, statements with respect to business operations, together with know-how improvement, anticipated revenues, projected dimension of market, and different data that’s primarily based on forecasts of future outcomes, estimates of quantities not but determinable and assumptions of administration.

Reliq Well being Applied sciences Inc. (the “Firm“) doesn’t intend and doesn’t assume any obligation, to replace these forward-looking statements besides as required by regulation. These forward-looking statements contain dangers and uncertainties referring to, amongst different issues, know-how improvement and advertising and marketing actions, the Firm’s historic expertise with know-how improvement, uninsured dangers. Precise outcomes could differ materially from these expressed or implied by such forward-looking statements.

SOURCE: Reliq Well being Applied sciences Inc.

Primary Logo

Previous post Audit finds safety breaches for Conn. Well being Insurance coverage Alternate
Next post College researchers discover that CBD helps struggle COVID-19 an infection in human cells